Literature DB >> 3574191

Guillain-Barré syndrome in Western Australia, 1980-1985.

G J Hankey.   

Abstract

A clinicoepidemiological study of 109 patients with Guillain-Barré syndrome who were admitted to the four major teaching hospitals in Perth between January 1, 1980 and December 31, 1985 was conducted through the Hospital Morbidity Data System. The annual incidence rate of Guillain-Barré syndrome was 1.35 cases per 100,000 population. The age-adjusted incidence rates were 1.49 cases per 100,000 men and 1.20 cases per 100,000 women. A minor peak in the sex-adjusted incidence rate was present in young adult life with a larger peak in later life. Twenty-two (20%) patients presented in the five-month period from July 1984 to November 1984 (P less than 0.05) but a common infectious agent or geographical area of residence was not discovered during this period. Immune function had been affected potentially before the onset of Guillain-Barré syndrome in 12 (11%) patients, which raises further speculation as to the role of immunological mechanisms in the pathogenesis of Guillain-Barré syndrome. In order to enhance our understanding of this disorder, it is recommended that an assessment of immune function be considered in cases of Guillain-Barré syndrome and also chronic inflammatory demyelinating polyneuropathy.

Entities:  

Mesh:

Year:  1987        PMID: 3574191     DOI: 10.5694/j.1326-5377.1987.tb120153.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  11 in total

Review 1.  Guillain-Barré syndrome.

Authors:  U Seneviratne
Journal:  Postgrad Med J       Date:  2000-12       Impact factor: 2.401

2.  Guillain-Barré syndrome in Taiwan: a clinical study of 167 patients.

Authors:  R K Lyu; L M Tang; S Y Cheng; W C Hsu; S T Chen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

3.  Guillain-Barré syndrome in Stockholm County, 1973-1991.

Authors:  G X Jiang; Q Cheng; A Ehrnst; H Link; J de Pedro-Cuesta
Journal:  Eur J Epidemiol       Date:  1997-01       Impact factor: 8.082

4.  Epidemiological features of Guillain-Barré syndrome in Sweden, 1978-93.

Authors:  G X Jiang; Q Cheng; H Link; J de Pedro-Cuesta
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-05       Impact factor: 10.154

5.  Occurrence, clinical manifestations, and prognosis of Guillain-Barré syndrome.

Authors:  H Rantala; M Uhari; M Niemelä
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

6.  The epidemiology of inflammatory polyradiculoneuropathy. A critical review of the distribution, characteristics and outcome of the disease. Plasmapheresis Study Group.

Authors:  E Beghi; F Cornelio; M Marconi; N Rizzuto; P Tonali
Journal:  Ital J Neurol Sci       Date:  1991-02

Review 7.  The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States.

Authors:  J Tuttle; R T Chen; H Rantala; J D Cherry; P H Rhodes; S Hadler
Journal:  Am J Public Health       Date:  1997-12       Impact factor: 9.308

8.  Malignant astrocytoma of the cervico-medullary junction masquerading as Guillain-Barré syndrome.

Authors:  S C Beards; L J Robertson; A Jackson; J Lipman
Journal:  Postgrad Med J       Date:  1994-07       Impact factor: 2.401

Review 9.  Vaccines and Guillain-Barré syndrome.

Authors:  Penina Haber; James Sejvar; Yann Mikaeloff; Frank DeStefano
Journal:  Drug Saf       Date:  2009       Impact factor: 5.228

10.  Variant Guillain-Barré Syndrome in a Patient with Non-Hodgkin's Lymphoma.

Authors:  R H Bishay; J Paton; V Abraham
Journal:  Case Rep Hematol       Date:  2015-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.